Azelastine hydrochloride/Fluticasone Sandoz nasal spray

Azelastine/Fluticasone Sandoz is a combination nasal spray used primarily for the treatment of allergic rhinitis. It combines an antihistamine with a corticosteroid to provide comprehensive relief from nasal symptoms. This specific product is a generic version of the brand Dymista, designed to offer a more affordable clinical alternative while maintaining same therapeutic efficacy.

The brand Sandoz has a rich history originating in Switzerland. Historically, Sandoz was a pioneer in the pharmaceutical and chemical sectors before merging with Ciba-Geigy in 1996 to form Novartis. In 2023, Sandoz completed a successful spin-off from Novartis to become an independent, publicly traded company. Since then, it has operated as a global leader in generic pharmaceuticals and biosimilars, maintaining its headquarters in Basel, Switzerland. Manufacturing for these products takes place across a specialized global supply chain, often including facilities in Europe and Asia to ensure wide availability.